These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26169957)

  • 61. ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy.
    Gallo S; Vitacolonna A; Bonzano A; Comoglio P; Crepaldi T
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052420
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of post-translational modifications in cardiac hypertrophy.
    Yan K; Wang K; Li P
    J Cell Mol Med; 2019 Jun; 23(6):3795-3807. PubMed ID: 30950211
    [TBL] [Abstract][Full Text] [Related]  

  • 63. H
    Chhabra A; Jain N; Varshney R; Sharma M
    Cell Signal; 2023 Jul; 107():110664. PubMed ID: 37004833
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Physiological and pathological cardiac hypertrophy.
    Shimizu I; Minamino T
    J Mol Cell Cardiol; 2016 Aug; 97():245-62. PubMed ID: 27262674
    [TBL] [Abstract][Full Text] [Related]  

  • 65. α
    Papay RS; Perez DM
    J Recept Signal Transduct Res; 2021 Apr; 41(2):138-144. PubMed ID: 32757689
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Catecholamines in cardiac hypertrophy.
    Scheuer J
    Am J Cardiol; 1999 Jun; 83(12A):70H-74H. PubMed ID: 10750591
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Effects of L-Arginine and α
    Zhang H; Zhang ZH; Zhang CS; Wang ZC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Dec; 42(6):815-819. PubMed ID: 33423731
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dual-omics reveals temporal differences in acute sympathetic stress-induced cardiac inflammation following α
    Zhang D; Zhao MM; Wu JM; Wang R; Xue G; Xue YB; Shao JQ; Zhang YY; Dong ED; Li ZY; Xiao H
    Acta Pharmacol Sin; 2023 Jul; 44(7):1350-1365. PubMed ID: 36737635
    [TBL] [Abstract][Full Text] [Related]  

  • 69. How cardiomyocytes sense pathophysiological stresses for cardiac remodeling.
    Haque ZK; Wang DZ
    Cell Mol Life Sci; 2017 Mar; 74(6):983-1000. PubMed ID: 27714411
    [TBL] [Abstract][Full Text] [Related]  

  • 70. PI3K kinase and scaffold functions in heart.
    Damilano F; Perino A; Hirsch E
    Ann N Y Acad Sci; 2010 Feb; 1188():39-45. PubMed ID: 20201884
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Beta-adrenoceptor signaling pathways mediate cardiac pathological remodeling.
    Fu Y; Xiao H; Zhang Y
    Front Biosci (Elite Ed); 2012 Jan; 4(5):1625-37. PubMed ID: 22201979
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Recent advances in alpha1-adrenoceptor pharmacology.
    Koshimizu TA; Tanoue A; Hirasawa A; Yamauchi J; Tsujimoto G
    Pharmacol Ther; 2003 May; 98(2):235-44. PubMed ID: 12725871
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oxidative Stress and Cardiac Remodeling: An Updated Edge.
    Rababa'h AM; Guillory AN; Mustafa R; Hijjawi T
    Curr Cardiol Rev; 2018 Mar; 14(1):53-59. PubMed ID: 29332590
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [THE ROLE OF ALPHA1-ADRENORECEPRORS FOR ACTIVITY OF THE HEART IN HUMANS AND ANIMALS. PART 1 (REVIEW)].
    Nozdrachyov AD; Tsirkin VI; Korotaeva YV
    Ross Fiziol Zh Im I M Sechenova; 2016 Feb; 102(2):130-45. PubMed ID: 29671479
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis.
    Samak M; Fatullayev J; Sabashnikov A; Zeriouh M; Schmack B; Farag M; Popov AF; Dohmen PM; Choi YH; Wahlers T; Weymann A
    Med Sci Monit Basic Res; 2016 Jul; 22():75-9. PubMed ID: 27450399
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Physiological myocardial hypertrophy: how and why?
    Catalucci D; Latronico MV; Ellingsen O; Condorelli G
    Front Biosci; 2008 Jan; 13():312-24. PubMed ID: 17981549
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Insulin signaling in the heart.
    Abel ED
    Am J Physiol Endocrinol Metab; 2021 Jul; 321(1):E130-E145. PubMed ID: 34056923
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Gender Differences in Cardiac Hypertrophy.
    Wu J; Dai F; Li C; Zou Y
    J Cardiovasc Transl Res; 2020 Feb; 13(1):73-84. PubMed ID: 31418109
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Alpha-1-adrenergic receptors: targets for agonist drugs to treat heart failure.
    Jensen BC; O'Connell TD; Simpson PC
    J Mol Cell Cardiol; 2011 Oct; 51(4):518-28. PubMed ID: 21118696
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The endocrinological component and signaling pathways associated to cardiac hypertrophy.
    Takano APC; Senger N; Barreto-Chaves MLM
    Mol Cell Endocrinol; 2020 Dec; 518():110972. PubMed ID: 32777452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.